The antioxidant activity of caroverine

Biochemical Pharmacology

Volumn 65, Issue 1, 2003, Pages 59-65

  Udilova, Natalia ^a   Kozlov, Andrey V ^a   Bieberschulte, Werner ^b   Frei, Klemens ^c   Ehrenberger, Klaus ^c   Nohl, Hans ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b PHAFAG AG   (Liechtenstein)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antioxidant; Caroverine; ESR; Iron; Lipid peroxidation; Spasmolytic drug

Indexed keywords

CAROVERINE; HYDROXYL RADICAL; SCAVENGER; SUPEROXIDE; XANTHINE; XANTHINE OXIDASE;

ANTIOXIDANT ACTIVITY; ARTICLE; CHEMICAL MODEL; CHEMICAL REACTION; DRUG MECHANISM; FENTON REACTION; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANTIOXIDANTS; CALCIUM CHANNEL BLOCKERS; EXCITATORY AMINO ACID ANTAGONISTS; HYDROXYL RADICAL; LIPID PEROXIDATION; QUINOXALINES; SUPEROXIDES; VITAMIN E;

EID: 0037212892     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01452-1     Document Type: Article

References (37)

1. Kudo Y., Shibata S. Effects of caroverine and diltiazem on synaptic responses, L-glutamate-induced depolarization and potassium efflux in the frog spinal cord. Br. J. Pharmacol. 83:1984;813-820.
2. Ehrenberger K., Felix D. Caroverine depresses the activity of cochlear glutamate receptors (in vivo model for drug-induced neuroprotection). Basic and clinical science of mental and addictive disorders. 167:1997;181-183.
3. Ehrenberger K., Felix D. Receptor pharmacological models for inner ear therapies with emphasis on glutamate receptors: a survey. Acta Otolaryngol. Stockh. 115:1995;236-240.
4. Anderer P., Saletu B. On the cerebro-protective effects of caroverine: double-blind, placebo-controlled, EEG mapping and psychometric studies under hypoxia. Basic and clinical science of mental and addictive disorders. 167:1997;190-194.
5. Saletu B., Grunberger J., Anderer P., Linzmayer L., Konig P. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration. Arzneimittelforschung. 45:1995;217-229.
6. Saletu B., Grunberger J., Anderer P., Linzmayer L. Central effects of acute intravenous and oral caroverine in man: double-blind, placebo-controlled, EEG mapping and psychometry. Basic and clinical science of mental and addictive disorders. 167:1997;184-189.
7. Hornykiewicz O., Hitzenberger G., Zellner H. Experimentell-pharmakologische und klinische Untersuchung über ein neues Spasmolytikum "Spadon" (Prüfbez. P. 201-1). Wien. Klin. Wochenschr. 11:1963;189-197.
8. Ehrenberger K. Clinical experience with caroverine in inner ear diseases. Adv. Otorhinolaryngol. 59:2002;156-162.
9. Profanter M. Erfahrungen mit hochdosiertem Caroverin bei zerebralen Durchblutungsstörungen. Therapiewoche. Österreich. 2:1987;926-935.
10. Saletu B., Grunberger J., Anderer P., Linzmayer L., Konig P. On the cerebro-protective effects of caroverine, a calcium-channel blocker and antiglutamatergic drug: double-blind, placebo-controlled, EEG mapping and psychometric studies under hypoxia. Br. J. Clin. Pharmacol. 41:1996;89-99.
11. Denk D.M., Ehrenberger K. Caroverine in the therapy of cochlear-synaptic tinnitus: a placebo-controlled blind study. Basic and clinical science of mental and addictive disorders. 167:1997;198-200.
12. Denk D.M., Heinzl H., Franz P., Ehrenberger K. Caroverine in tinnitus treatment. A placebo-controlled blind study. Acta Otolaryngol. Stockh. 117:1997;825-830.
13. Burcham P.C. Genotoxic lipid peroxidation products: their DNA damaging properties and role in formation of endogenous DNA adducts. Mutagenesis. 13:1998;287-305.
14. Marnett L.J. Oxyradicals and DNA damage. Carcinogenesis. 21:2000;361-370.
15. Eckl P.M., Ortner A., Esterbauer H. Genotoxic properties of 4-hydroxyalkenals and analogous aldehydes. Mutat. Res. 290:1993;183-192.
16. Esterbauer H. Cytotoxicity and genotoxicity of lipid-oxidation products. Am. J. Clin. Nutr. 57:1993;779S-785S.
17. Lipinski B. Pathophysiology of oxidative stress in diabetes mellitus. J. Diabetes Complications. 5:2001;203-210.
18. Aviram M. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radic. Res. 3(Suppl):2000;S85-S97.
19. Lefer D.J., Granger D.N. Oxidative stress and cardiac disease. Am. J. Med. 9:2000;315-323.
20. Halliwell B. Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward? Cardiovasc. Res. 7:2000;410-418.
21. Cerutti P.A. Prooxidant states and tumor promotion. Science. 27:1985;375-381.
22. Rosen P., Nawroth P.P., King G., Moller W., Tritschler H.J., Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab. Res. Rev. 7:2001;189-212.
23. Nohl H. Involvement of free radicals in aging: a consequence or cause of senescence. Br. Med. Bull. 9:1993;653-667.
24. Nohl H. Biologie und Toxikologie des Sauerstoffs. In: Uranüs S, editor. Chirurgische Forschung, Zuckerschwerdt. Verlag: Wien; 1994, p. 59-80.
25. Liu Y., Stolze K., Dadak A., Nohl H. Light emission resulting from hydroxylamine induced singlet oxygen formation of oxidizing LDL-particles. Photochem. Photobiol. 66(4):1997;443-449.
26. + oxidoreductase. J. Biol. Chem. 263:1988;1204-1211.
27. Naito Y., Yoshikawa T., Tanigawa T., Sakurai K., Yamasaki K., Uchida M., Kondo M. Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study. Free Radic. Biol. Med. 18:1995;117-123.
28. 2. J. Phys. Chem. 95:1991;5116-5120.
29. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. Oxford: Clarendon Press; 1985, p. 84-91.
30. -· radicals in aqueous solution. J. Phys. Chem. 14(4):1985;1041-1099.
31. Finkelstein E., Rosen G.M., Rauckman E.J. Spin trapping Kinetics of the reaction of superoxide and hydroxyl radicals with nitrones. J. Am. Chem. Soc. 102:1980;4994-4999.
32. Armstrong R.C., Swallow A.J. Pulse- and gamma-radiolysis of aqueous solutions of tryptophan. Radiat. Res. 40:1969;563-579.
33. Iddon B., Phillips G.O., Robbins K.E., Davies J.V. Radiation chemistry of aqueous solutions of indoles and its derivatives. J. Chem. Soc. B:1971;1887-1892.
34. Seidman M.D. Glutamate antagonists, steroids and antioxidants as therapeutic options for hearing loss and tinnitus and the use of an inner ear drug delivery system. Int. Tinnitus J. 4:1998;148-154.
35. Eybalin M., Pujol R. Cochlear neuroactive substances. Arch. Otorhinolaryngol. 246:1989;228-234.
36. Pujol R., Puel J.L., Gervais D.C., Eybalin M. Pathophysiology of the glutamatergic synapses in the cochlea. Acta Otolaryngol. 113:1993;330-334.
37. Seidman M.D. Effects of dietary restriction and antioxidants on presbyacusis. Laryngoscope. 110:2000;727-738.